CATHETER-ASSOCIATED URINARY TRACT INFECTIONS AND ANTIMICROBIAL SENSITIVITY PATTERN OF ORGANISMS IN INTENSIVE CARE UNIT PATIENTS AT A TERTIARY CARE HOSPITAL.
Main Article Content
Keywords
catheter-associated urinary tract infection (CAUTI); Klebsiella pneumoniae; hospital acquired infections; Proteus mirabilis; Pseudomonas aeruginosa; antibiogram
Abstract
Introduction: Catheter-associated urinary tract infections (CAUTIs) represent one of the leading types of hospital-acquired infections (HAIs) worldwide.[1] Extended hospital stays, the use of invasive medical devices such as indwelling urinary catheters, and inappropriate or excessive administration of antimicrobial drugs are widely recognized as key contributors to the rising incidence of HAIs.[2] Among critically ill patients with urinary catheters, infections including pyelonephritis, urethritis, cystitis, and prostatitis are frequently observed and pose significant clinical challenges. Gram-negative organisms are predominantly responsible for these infections in intensive care unit (ICU) settings.[3]
Method: This investigation was designed as a cross-sectional, hospital-based study carried out in the Department of Microbiology at a tertiary care teaching hospital. Urine samples were collected from catheterized patients and cultured on CLED agar. Isolated colonies were identified and antibacterial susceptibility testing was performed by an automated method i.e. Vitek Compact.
Result: This investigation was conducted to assess the prevalence of CAUTI, identify the causative microorganisms, evaluate their antimicrobial susceptibility profiles, and analyse associated risk factors to support evidence-based prevention strategies. During the study period, 350 patients were admitted to the ICU, and healthcare-associated infections were documented in 105 cases. Of these, 35 patients were diagnosed specifically with CAUTI. Microbiological analysis revealed that Klebsiella pneumoniae (28.6%) was the most frequently isolated pathogen, followed by Pseudomonas aeruginosa (20%), Proteus mirabilis (14.3%), Acinetobacter baumannii (11.4%), Enterococcus faecalis (5.7%), and Staphylococcus aureus (5.7%). These findings highlight the predominance of Gram-negative bacteria in CAUTI cases within the ICU population.
Conclusion: Gram-negative bacteria predominated, with a high frequency of multidrug-resistant strains and significant beta-lactamase production.
These findings have important clinical implications. Continuous surveillance of local antibiogram patterns, strict adherence to catheter care protocols, early catheter removal, and implementation of robust antibiotic stewardship programs are essential to reduce CAUTI rates and combat antimicrobial resistance. The data generated may assist healthcare institutions in developing targeted infection prevention strategies and optimizing empirical treatment guidelines at a national level.
References
2. Storme, O.; Tiran Saucedo, J.; Garcia-Mora, A.; Dehesa-Davila, M.; Naber, K.G. Risk factors and predisposing conditions for urinary tract infection. Ther. Adv. Urol. 2019, 11, 1756287218814382. [CrossRef]
3. Asmare Z, Awoke T, Genet C, Admas A, Melese A, Mulu W. Incidence of catheter- associated urinary tract infections by Gram-negative bacilli and their ESBL and carbapenemase production in specialized hospitals of Bahir Dar, northwest Ethiopia.
4. Antimicrob Resist Infect Control. 2024 Jan 25;13(1):10. doi: 10.1186/s13756-024- 01368-7. PMID: 38273339; PMCID: PMC10809431.
5. Obaid, N.A. Preventive Measures and Management of Catheter-Associated Urinary Tract Infection in Adult Intensive Care Units in Saudi Arabia. J. Epidemiol. Glob. Health 2021, 11, 164–168. [CrossRef]
6. Storme, O.; Tiran Saucedo, J.; Garcia-Mora, A.; Dehesa-Davila, M.; Naber, K.G. Risk factors and predisposing conditions for urinary tract infection. Ther. Adv. Urol. 2019, 11, 1756287218814382. [CrossRef]
7. Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes. Al-Rubeaan KA, Moharram O, Al-Naqeb D, Hassan A, Rafiullah MR. World J Urol. 2013;31:573–578. doi: 10.1007/s00345-012-0934-x. [DOI] [PubMed] [Google Scholar
8. Pineiro Perez, R.; Cilleruelo Ortega, M.J.; Ares Alvarez, J.; Baquero-Artigao, F.; Silva Rico, J.C.; Velasco Zuniga, R.; Martinez Campos, L.; Carazo Gallego, B.; Conejo Fernandez, A.J.; Calvo, C.; et al. Recommendations on the diagnosis and treatment of urinary tract infection. An. Pediatr. Engl. Ed. 2019, 90, 400.e1–400.e9. [CrossRef]
9. Ekwealor, P.A.; Ugwu, M.C.; Ezeobi, I.; Amalukwe, G.; Ugwu, B.C.; Okezie, U.; Stanley, C.; Esimone, C. Antimicrobial Evaluation of Bacterial Isolates from Urine Specimen of Patients with Complaints of Urinary Tract Infections in Awka, Nigeria. Int. J. Microbiol. 2016, 2016, 9740273. [CrossRef] [PubMed]
10. CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 30th ed.; CLSI Supplement M100; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2020; p. 16.
11. Werneburg GT. Catheter-Associated Urinary Tract Infections: Current Challenges and Future Prospects. Res Rep Urol. 2022 Apr 4;14:109-133. doi: 10.2147/RRU.S273663. PMID: 35402319; PMCID: PMC8992741.
12. Vinoth, M.; Prabagaravarthanan, R.; Bhaskar, M. Prevalence of microorganisms causing catheter associated urinary tract infections (CAUTI) among catheterised patients admitted in a tertiary care hospital. Int. J. Res. Med. Sci. 2017, 5, 2367–2372. [CrossRef]
13. Bizuayehu, H.; Bitew, A.; Abdeta, A.; Ebrahim, S. Catheter-associated urinary tract infections in adult intensive care units at a selected tertiary hospital, Addis Ababa, Ethiopia. PLoS ONE 2022, 17, e0265102. [CrossRef] [PubMed]
14. Erben, N.; Alpat, S.N.; Kartal, E.D.; Ozgunes, I.; Usluer, G. Analysis of the risk factors in nosocomial urinary tract infections and effect of urinary catheter use on distribution of the causative agents. Mikrobiyoloji Bul. 2009, 43, 77–82.
15. Clec’h, C.; Schwebel, C.; Francais, A.; Toledano, D.; Fosse, J.P.; Garrouste-Orgeas, M.; Azoulay, E.; Adrie, C.; Jamali, S.; Descorps-Declere, A.; et al. Does catheter-associated urinary tract infection increase mortality in critically ill patients? Infect. Control Hosp. Epidemiol. 2007, 28, 1367–1373. [CrossRef]
16. Keten, D.; Aktas, F.; Guzel Tunccan, O.; Dizbay, M.; Kalkanci, A.; Biter, G.; Keten, H.S. Catheter-associated urinary tract infections in intensive care units at a university hospital in Turkey. Bosn. J. Basic Med. Sci. 2014, 14, 227–233. [CrossRef]
17. Verma, S.; Naik, S.; Deepak, T. Etiology and risk factors of catheter associated urinary tract infections in ICU patients. Int. J. Med. Microbiol. Trop. Dis. 2017, 3, 65–70.
18. Platt, R.; Polk, B.F.; Murdock, B.; Rosner, B. Mortality associated with nosocomial urinary-tract infection. N. Engl. J. Med. 1982, 307, 637–642. [CrossRef]
19. Foxman, B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Am. J. Med. 2002, 113 (Suppl.1A), 5S–13S. [CrossRef]
20. Kamat, U.S.; Fereirra, A.; Amonkar, D.; Motghare, D.D.; Kulkarni, M.S. Epidemiology of hospital acquired urinary tract infections in a medical college hospital in Goa. Indian J. Urol. 2009, 25, 76–80. [CrossRef]
21. Jha T, Khaparde M, Parkhe TS, Purandare B, Lavate R. Incidence Risk Factors and Drug Resistance Patterns of Bacterial Isolates in Patients with Catheter-associated Urinary Tract Infections. Indian J Crit Care Med 2025; 29 (4):338-344. DOI: 10.5005/jp-journals-10071-24932
22. Parihar S, Sharma R, Kinimi SV, Choudhary S. An Observational Study from Northern India to Evaluate Catheter-associated Urinary Tract Infection in Medical Intensive Care Unit at a Tertiary Care Centre. Indian J Crit Care Med 2023; 27 (9):642-646. DOI: 10.5005/jp-journals-10071- 24519
23. Li N, Shi R, Sun Y, Chen Q. Effective interventions to prevent catheter-associated urinary tract infections: a systematic review. Rev Inst Med Trop Sao Paulo. 2025 Oct 3;67:e61. doi: 10.1590/S1678-9946202567061. PMID: 41059852; PMCID: PMC12499511.
24. Li N, Shi R, Sun Y, Chen Q. Effective interventions to prevent catheter-associated urinary tract infections: a systematic review. Rev Inst Med Trop Sao Paulo. 2025 Oct 3;67:e61. doi: 10.1590/S1678-9946202567061. PMID: 41059852; PMCID: PMC12499511.
25. Podkovik, S.; Toor, H.; Gattupalli, M.; Kashyap, S.; Brazdzionis, J.; Patchana, T.; Bonda, S.; Wong, S.; Kang, C.; Mo, K.; et al. Prevalence of Catheter-Associated Urinary Tract Infections in Neurosurgical Intensive Care Patients—The Overdiagnosis of Urinary Tract Infections. Cureus 2019, 11, e5494. [CrossRef]
26. Getliffe, K.; Newton, T. Catheter-associated urinary tract infection in primary and community health care. Age Ageing 2006, 35, 477–481. [CrossRef]
27. Alzahrani, M.A.; Ali, M.S.; Anwar, S. Bacteria Causing Urinary Tract Infections and Its Antibiotic Susceptibility Pattern at Tertiary Hospital in Al-Baha Region, Saudi Arabia: A Retrospective Study. J. Pharm. Bioallied Sci. 2020, 12, 449–456. [CrossRef]
28. Behzadi, P.; Behzadi, E.; Yazdanbod, H.; Aghapour, R.; Akbari Cheshmeh, M.; Salehian Omran, D. A survey on urinary tract infections associated with the three most common uropathogenic bacteria. Maedica 2010, 5, 111–115. [PubMed]
29. Rahman, M.R.; Sultana, S.; Rahman, R.; Akhtar, N. Antimicrobial Sensitivity Pattern of Bacterial Pathogens Associated with Urinary Tract Infection. Delta Med. Coll. J. 2017, 5, 57–62. [CrossRef]
30. El-Kersh, T.; Marie, M.; Al-Sheikh, Y.; Al-Kahtani, S. Prevalence and risk factors of community-acquired urinary tract infections due to ESBL-producing Gram negative bacteria in an Armed Forces Hospital in Sothern Saudi Arabia. Glob. Adv. Res. J. Med. Med. Sci. 2015, 4, 321–330.
31. Albert Dawn, T.N. Lahiri A Study on Catheter Associated Urinary Tract Infections (Cauti) and Antibiotic Sensitivity Pattern of Uropathogens Causing Cauti, | Volume 15 Issue 6 (June, 2025) | Pages 627 – 629 DOI : 10.5083/ejcm/25-06-101
32. Kiongo NK, Maingi JM, Nyongesa KW, Musyoki AM. Extended-spectrum β-lactamase and carbapenemase-producing bacteria urinary tract infections in adult HIV-positive
33. outpatients at Embu County Referral Hospital, Kenya. BMC Microbiol. 2025 Nov 14;25(1):743. doi: 10.1186/s12866-025-03872-1. PMID:

